PHARMACOKINETICS OF HALOPERIDOL

被引：118
|
作者：
FROEMMING, JS
LAM, YWF
JANN, MW
DAVIS, CM
机构：
[1] MERCER UNIV,SO SCH PHARM,DEPT PHARM PRACTICE,ATLANTA,GA
[2] UNIV TEXAS,HLTH SCI CTR,DIV CLIN PHARM,SAN ANTONIO,TX 78284
[3] UNIV TEXAS,COLL PHARM,AUSTIN,TX 78712
[4] UNIV TEXAS,INST MENTAL SCI INST,HOUSTON,TX 77025
来源：
CLINICAL PHARMACOKINETICS | 1989年 / 17卷 / 06期
关键词：
D O I：
10.2165/00003088-198917060-00004
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：396 / 423
页数：28
相关论文
共 50 条
  • [31] ACUTE DOSE AND STEADY-STATE HALOPERIDOL PHARMACOKINETICS IN SCHIZOPHRENIA
    KIRCH, DG
    KORPI, E
    VENABLE, D
    BIGELOW, LB
    WYATT, RJ
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 685 - 686
  • [32] The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine
    Potkin, SG
    Thyrum, PT
    Alva, G
    Bera, R
    Yeh, C
    Arvanitis, LA
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (02) : 121 - 130
  • [33] DISTRIBUTION AND METABOLISM OF NEUROLEPTIC DRUGS .1. PHARMACOKINETICS OF HALOPERIDOL
    LEWI, PJ
    HEYKANTS, JJ
    ALLEWIJN, FT
    DONY, JGH
    JANSSEN, PAJ
    ARZNEIMITTEL-FORSCHUNG, 1970, 20 (07): : 943 - &
  • [34] HALOPERIDOL-INDUCED CHANGES IN THE REGIONAL CEREBRAL PHARMACOKINETICS OF APOMORPHINE
    MELZACKA, M
    WISZNIOWSKA, G
    DANIEL, W
    VETULANI, J
    POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1979, 31 (04): : 387 - 391
  • [35] HALOPERIDOL DECANOATE PHARMACOKINETICS IN RED-BLOOD-CELLS AND PLASMA
    DYSKEN, MW
    KIM, SW
    VATASSERY, G
    JOHNSON, SB
    SKARE, S
    HOLDEN, L
    THOMSYCK, L
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1992, 12 (02) : 128 - 132
  • [36] GAS-CHROMATOGRAPHIC METHOD FOR DETERMINING HALOPERIDOL - SENSITIVE PROCEDURE FOR STUDYING SERUM CONCENTRATION AND PHARMACOKINETICS OF HALOPERIDOL IN PATIENTS
    FORSMAN, A
    MARTENSSON, E
    NYBERG, G
    OHMAN, R
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1974, 286 (02) : 113 - 124
  • [37] STEADY-STATE PHARMACOKINETICS OF HALOPERIDOL AND REDUCED HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS - ANALYSIS OF FACTORS DETERMINING THEIR CONCENTRATIONS IN HAIR
    UEMATSU, T
    MATSUNO, H
    SATO, H
    HIRAYAMA, H
    HASEGAWA, K
    NAKASHIMA, M
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (10) : 1008 - 1011
  • [38] PHARMACOKINETICS OF HALOPERIDOL DECANOATE - A 2-YEAR FOLLOW-UP
    REYNTJENS, AJM
    HEYKANTS, JJP
    WOESTENBORGHS, RJH
    GELDERS, YG
    AERTS, TJL
    INTERNATIONAL PHARMACOPSYCHIATRY, 1982, 17 (04): : 238 - 246
  • [39] STEADY-STATE PHARMACOKINETICS OF ORAL HALOPERIDOL AFTER RAPID NEUROLEPTIZATION
    FLOYD, R
    NEBERSKY, R
    HORNBECK, C
    JANOWSKI, D
    GRIFFITHS, J
    BOEHM, R
    JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 22 (04): : A7 - A7
  • [40] AGE EFFECTS ON HALOPERIDOL PHARMACOKINETICS IN MALE, FISCHER-344 RATS
    KAPETANOVIC, IM
    SWEENEY, DJ
    RAPOPORT, SI
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1982, 221 (02): : 434 - 438
12345